Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000448 · ClinicalTrials.gov registry record · Phase 4
Naltrexone Treatment for Alcoholic Women
A Phase 4 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 160
- Enrollment target
NCT00000448 is a Phase 4 study that has completed, run by Yale University. The registered enrollment target is 160 participants.
The verdict
NCT00000448, a Phase 4 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 160 participants
- Enrollment target
Study Summary
This study will assess naltrexone's effectiveness in treating alcoholism in women and provide information on its potential value in treating eating disorders common among alcoholic women. Alcoholic women with and without both eating disorders and depression will be randomly assigned to placebo or naltrexone treatment. Each group will receive behavioral therapy for 12 weeks, with followup 6 months after treatment.
Interventions
- DRUG Placebo
- DRUG naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 1995-10 |
| Est. Completion | 2000-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000448
The ClinicalTrials.gov registry entry for NCT00000448 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00000448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000448 about?
NCT00000448 is a clinical study titled "Naltrexone Treatment for Alcoholic Women". This study will assess naltrexone's effectiveness in treating alcoholism in women and provide information on its potential value in treating eating disorders common among alcoholic women. Alcoholic women with and without both eating disorders and depression will be randomly assigned to placebo or na...
What is the current status of trial NCT00000448?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 160 participants. The study started on 1995-10. Estimated completion is 2000-12.
What interventions are being tested in trial NCT00000448?
The interventions under investigation include: Placebo (DRUG), naltrexone (DRUG).
Who is sponsoring clinical trial NCT00000448?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.